Cresemba 186 MG capsule UD 14S
Ended Awarded
- Contract number
- SPE2DX25F6MZT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $11,338
Award facts
- Contract value 100% obligated
- $11,338.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $11,338.42 to AmerisourceBergen Drug Corp for the supply of Cresemba 186 mg capsules (14-count unit dose packaging) on May 2, 2025, with completion scheduled for May 5, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award issued under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract vehicle, designated SPE2DX, functions as a comprehensive global pharmaceutical support platform enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected for this delivery order based on its established capability to meet federal procurement requirements through the existing DLA Troop Support Medical contract. The company serves as a critical vendor for Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with a demonstrated track record of fulfilling federal pharmaceutical and medical supply needs across multiple therapeutic domains. The DLA Pharmaceutical Prime Vendor Global Program represents a strategic approach to ensure reliable supply chains for military medical support, with plans for multiple regional awards to maintain competitive procurement practices.
Quick answers
Who was awarded contract SPE2DX25F6MZT?
SPE2DX25F6MZT was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on May 2, 2025.
How much is contract SPE2DX25F6MZT worth?
The government has obligated $11,338 on SPE2DX25F6MZT.
Is contract SPE2DX25F6MZT an order under another contract?
Yes. SPE2DX25F6MZT is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6MZT competed?
The extent of competition for SPE2DX25F6MZT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award